Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Doblin

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Plos One|March 17, 2021
The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trialMarcel O Bonn-Miller, Sue Sisley, Paula Riggs, et al.
Frontiers in Psychiatry|January 30, 2023
Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorderS Parker Singleton, Julie B Wang, Michael Mithoefer, et al.
Physiology & Behavior|December 12, 2018
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in ratsHolly S Hake, Jazmyne K P Davis, River R Wood, et al.
Journal of Psychopharmacology (Oxford, England)|October 30, 2018
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trialMarcela Ot'alora G, Jim Grigsby, Bruce Poulter, et al.
Scientific Reports|November 25, 2020
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot studyPhilip E Wolfson, Julane Andries, Allison A Feduccia, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|July 9, 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in BrazilAlvaro V Jardim, Dora V Jardim, Bruno Rasmussen Chaves, et al.
Nature Medicine|September 14, 2023
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trialJennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, et al.
Nature Medicine|May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Lancet. Psychiatry|May 6, 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trialMichael C Mithoefer, Ann T Mithoefer, Allison A Feduccia, et al.
European Journal of Psychotraumatology|January 7, 2021
MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trialCandice M Monson, Anne C Wagner, Ann T Mithoefer, et al.
Plos One|March 17, 2021
The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trialMarcel O Bonn-Miller, Sue Sisley, Paula Riggs, et al.
Frontiers in Psychiatry|January 30, 2023
Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorderS Parker Singleton, Julie B Wang, Michael Mithoefer, et al.
Physiology & Behavior|December 12, 2018
3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in ratsHolly S Hake, Jazmyne K P Davis, River R Wood, et al.
Journal of Psychopharmacology (Oxford, England)|October 30, 2018
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trialMarcela Ot'alora G, Jim Grigsby, Bruce Poulter, et al.
Scientific Reports|November 25, 2020
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot studyPhilip E Wolfson, Julane Andries, Allison A Feduccia, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|July 9, 2020
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in BrazilAlvaro V Jardim, Dora V Jardim, Bruno Rasmussen Chaves, et al.
Nature Medicine|September 14, 2023
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trialJennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, et al.
Nature Medicine|May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Pageof 4